TECNOTREE
23.2.2024 10:30:26 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, announced the simultaneous rollout of their digital BSS solutions for telecom service providers spanning across the Middle East and Africa. The milestone included 14 Go-lives globally for some of the largest Telecom, Healthcare and Realty groups across North America, the Middle East, Africa and Latam, delivering large-scale Digital BSS transformation for customers on public and private cloud through the Tecnotree Digital Suite (Tecnotree Edge).
The digital stack deployed under various transformation projects include Out of the Box capabilities of Tecnotree’s Digital Suite: Debt Management System, BSS-Switch with Convergent Online Charging System (COCS), Service Provisioning System (SPS), New Bill Layout Designer (BLD), Customer Lifecycle Manager (CLM), and more. By leveraging Tecnotree’s AI-powered, intelligent digital solutions, service providers will be able to align their capabilities with the evolving business needs. The comprehensive solutions will help deliver superior digital customer experience and transformation, introducing the next generation of services for their customers.
Tecnotree’s digital suite empowers robust capabilities for customer tracking across various channels, providing an enhanced 360-degree view of all interactions. This highly automated, full Digital stack, coupled with TMF Open API and ODA Compliant Architecture, facilitates faster service rollouts, ushering in new levels of agility and speed in an increasingly competitive and fast-paced market.
Padma Ravichander, CEO of Tecnotree Corporation said, “We take immense pride in the successful series of go-lives as they represent our unwavering focus on delivering large-scale digital transformation for our customers across various regions. We are enabling the next wave of digital transformation, aligning with the rapidly growing markets. The multiple and simultaneous go-lives speak to the predictability and stability of the Tecnotree Digital Stack in terms of its reliability, dynamic version upgrades, and autopilot capabilities.
With Tecnotree's comprehensive full-stack solution, operators can deliver new and innovative value-added services, unlocking new opportunities and revenue streams. The digital transformations will propel operational efficiencies for operators, enabling them to deliver personalized customer engagement while ensuring seamless and rapid upgrades of features. The offerings will be combined with deep insights in terms of customer experiences, with our embedded, augmented, and cognitive AI use cases on the stack.”
Ramaseshan Subramanian, Chief Delivery Officer, SVP Tecnotree said, “Overseeing the parallel launches of our cutting-edge digital BSS solutions for major telecom providers across the Middle East and Africa has been a testament to our commitment to provide the best-in-class delivery in an agile customer-success driven environment. Our accomplishment of orchestrating 14 successful go-lives for major operator groups worldwide represents a milestone in delivering extensive Digital BSS transformations through the Tecnotree Digital Suite, and further strengthens our commitment to enhance customer-centricity and operational efficiency.”
Shahbaz Ahmad Rashid, Head MEA & Europe, SVP Sales Tecnotree Corporation said, “We’re thrilled about the various successful go-lives which will accelerate digital transformation and deliver world-class experiences to our customers. With the intelligent, digital solutions from Tecnotree, these Opcos will be in a better position to meet the evolving needs of customers, while also accelerating sales, streamlining operations, and driving new monetization opportunities.”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223931032/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom